The effect of the common Covid-19 antibiotic is similar to that of placebo

The effect of the common Covid-19 antibiotic is similar to that of placebo

California: A new study from UC San Francisco shows that the antibiotic azithromycin covid 19 in non-hospitalized patients was no more effective than placebo in preventing symptoms. Despite extensive prescriptions for antibiotics for this disease, it can increase the chances of hospitalization.
The study, conducted in collaboration with Stanford University, was published in the Journal of the American Medical Association.
“These findings do not support the routine use of azathiomycin for outpatient SARS-Co-2 infections,” said Catherine E. Oldenberg, MPH, an assistant professor at the UCSF Proctor Foundation. Stork is a CoV-2 virus that causes CoV-19.
Azithromycin, a viscous spectrum antibiotic, is widely used in the United States and around the world as a treatment for Covid 19. “The hypothesis is that it has anti-inflammatory properties that, in the early stages of the disease, can help prevent progression,” said Oldenberg. “We didn’t find that.”
The study included 263 participants who tested positive for SARS Covey 2 within seven days of entering the study. No one was hospitalized at the time of enrollment. In the random selection process, 171 participants received one, 1.2 grams of oral dose of azithromycin and 92 received identical placebo.
For 14 days of the study, 50% of the participants in both groups remained symptom-free. By day 21, five of the participants who had received azithromycin had been hospitalized with severe symptoms of covid 19, and none of the placebo group had been hospitalized.
The researchers concluded that a single dose of azithromycin was less likely to be cured than placebo.
“Most trials with azithromycin so far have focused on patients with severe illnesses admitted to hospitals,” Oldenberg said. “For the first time, our article is included in a placebo-controlled study that showed no role for azithromycin in outpatients.”

STAY TUNED WITH US FOR MORE INTERESTING CONTENT ONLY ON DESINEW.XYZ

Leave a Reply

Your email address will not be published. Required fields are marked *